Early career · publishing since 2019Rising activity
Cancer Cells and MetastasisCancer, Hypoxia, and MetabolismEstrogen and related hormone effectsBone health and treatmentsHER2/EGFR in Cancer Research
Publications
69
Citations
206
Est. group size
~7
Recurring co-author estimate
Active years
8
Publishing since 2019
In context
Among 1,353 early career Medicine PIs within our index
Citations: 206p25 74 · p75 317 · cohort median 157
Publications / year (recent): 13.4p25 1.8 · p75 4.4 · cohort median 2.6
Typically publishes in teams of ~10 · 0% small-team papers (≤3 authors) · across 7 venues
Publication cadence
Publications per year over the last 10 years — averaging 13.4/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Inhibiting stearoyl‐ <scp>CoA</scp> desaturase suppresses bone metastatic prostate cancer by modulating cellular stress, <scp>mTOR</scp> signaling, and <scp>DNA</scp> damage response
FEBS Letters · 2026
- Abstract 5109: ATF4 and SCD: Co-conspirators in promoting the progression of metastatic prostate cancer in bone
Cancer Research · 2025
- Targeting SCD in SCD-amplified prostate cancer inhibits growth in bone by modulating cellular stress, mTOR, and DNA damage pathways
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Figure S8 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S2 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Supplementary Table 1 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S1 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S6 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S5 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S7 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S4 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S3 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S2 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S7 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
- Figure S5 from Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer
2025
Publishes in
- Molecular Cancer Research×2
- Oncogene×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- iScience×1
- Journal of Clinical Investigation×1
Similar researchers
By research-topic overlap
- Alyssa C. Cutter
Medicine · University of Michigan
- Johanna M. Buschhaus
Medicine · University of Michigan
- Tanner H. Robison
Medicine · University of Michigan
- Siyi Chen
Medicine · University of Michigan
- Brock A. Humphries
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile